NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-20-041 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is for a Coordinating Center for the NCI Pediatric in Vivo Testing Program (henceforth termed the Ped-In Vivo-TP). The main goal for the Ped-InVivo-TP is to use genomically-characterized pediatric cancer models to develop a rigorous preclinical testing system to generate reliable data that can be used to inform new agent prioritization decisions for childhood cancers. The Ped-In Vivo-TP has two parts: a) research teams for in vivo testing to determine the activity of pediatric anticancer drug candidat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 25, 2020 Category: Research Source Type: funding

Institute and Center Award Rates and Funding Disparities
In 2011, Ginther et al. first demonstrated that African American and Black applicants to the National Institutes of Health received grant awards at a lower rate than their white counterparts (Ginther 2011). Since then, multiple studies have reproduced and extended this finding (Ginther 2011; Ginther 2016; Hoppe 2019; Erosheva 2020). Recently we reported that African American and Black (AAB) PIs are more likely to propose research on topics that are less likely  to be funded (Hoppe 2019). We found that topic choice has little or no effect on whether an application is chosen for discussion, but after consideri...
Source: NIH Extramural Nexus - August 12, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike Funding data Source Type: funding

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Funding Opportunity PAR-20-285 from the NIH Guide for Grants and Contracts. This FOA encourages applications for multi-site exploratory and confirmatory clinical trials focused on promising interventions; biomarker or outcome measure validation studies that are immediately preparatory to trials in stroke prevention, treatment, and recovery; and ancillary studies designed to add scientific aims to active studies being conducted within StrokeNet. Successful applicants will collaborate and conduct the study within the NIH StrokeNet. Following peer review, NINDS will prioritize studies among the highest scoring to be conducte...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 29, 2020 Category: Research Source Type: funding

Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
Funding Opportunity PAR-20-230 from the NIH Guide for Grants and Contracts. The Center for Inherited Disease Research (CIDR) high-throughput genotyping, sequencing and supporting statistical genetics services are designed to aid the identification of genes or genetic modifications that contribute to human health and disease or to enhance existing collections of well-phenotyped specimens by the addition of genotype or next-generation sequence data. The laboratory specializes in genomic services that cannot be efficiently carried out in individual investigator laboratories. CIDR provides the most up-to-date platforms, servi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 11, 2020 Category: Research Source Type: funding

Advancing HIV/AIDS Research through Computational Neuroscience FOA (R01 - Clinical Trial Optional)
Funding Opportunity RFA-DA-21-013 from the NIH Guide for Grants and Contracts. This funding opportunity announcement invites computational HIV/AIDS research as it relates to NIDAs mission through collaborative research between investigators with experimental expertise related to HIV/AIDS and those with computational proficiency, including scientists from statistics, physics, mathematics, engineering, and computer science. An R01 research project should build on well-established computational strategies (theory, models, and methods) to investigate HIV-related neurocognitive deficits and neuropathogenesis in the context of ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 2, 2020 Category: Research Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
Funding Opportunity PA-20-199 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 7, 2020 Category: Research Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required)
Funding Opportunity PA-20-197 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 7, 2020 Category: Research Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required)
Funding Opportunity PA-20-198 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 7, 2020 Category: Research Source Type: funding

How Many Researchers: Positive Trends Continue in FY 2019
As we continue to explore the question of how many researchers NIH funds, we have been observing a positive trend over the last few years where the number of unique scientists seeking support on NIH research project grants (RPGs) is stabilizing along with a commensurate rise in the corresponding NIH cumulative investigator rate (see these posts from 2019, 2018, and 2016). Now with fiscal year (FY) 2019 data available on the NIH Data Book, let’s see if this trend continued. NIH’s cumulative investigator rate, as a reminder, is a person-based metric that looks at the likelihood that unique investigators are f...
Source: NIH Extramural Nexus - February 25, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike cumulative investigator rate P01 R01 R21 RPG Source Type: funding

NSF-Simons Research Collaborations on the Mathematical and Scientific Foundations of Deep Learning (MoDL)
Letter of Intent Deadline Date: March 20, 2020 Program Guidelines: NSF 20-540The National Science Foundation Directorates for Mathematical and Physical Sciences (MPS), Computer and Information Science and Engineering (CISE), Engineering (ENG), and the Simons Foundation Division of Mathematics and Physical Sciences will jointly sponsor up to two new research collaborations consisting of mathematicians, statisticians, electrical engineers, and theoretical computer scientists. Research activities will be focused on explicit topics involving some of the most challenging ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_...
Source: NSF Upcoming Due Dates - February 19, 2020 Category: Science Source Type: funding

What ’s Happening With “At-Risk Investigators?”
In December 2018, the NIH Advisory Committee to the Director (ACD) offered a number of recommendations to NIH on the “Next Generation Researchers Initiative.”  Among those: The Committee recommended “special funding consideration for “at-risk” investigators. These are researchers who developed meritorious applications who would not have significant NIH research funding if the application under consideration is not awarded. We plan to draw more attention this year, both inside and outside NIH, to outcomes for at-risk investigators, to ensure those submitting meritorious ideas to NIH are no...
Source: NIH Extramural Nexus - February 7, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike at risk investigators Early Stage Investigator NGRI Source Type: funding

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
Funding Opportunity RFA-CA-20-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2020 Category: Research Source Type: funding

KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
Funding Opportunity RFA-DK-19-032 from the NIH Guide for Grants and Contracts. The purpose of the Kidney, Urology or Hematology (KUH) Predoctoral to Postdoctoral Fellow Transition Awards (F99/K00) is to recruit exceptional graduate students from diverse research fields to pursue postdoctoral training focused on Kidney, Urology or Hematology (K, U, or H) research. Talented graduate students from disciplines including, but not limited to, engineering, statistics, data science, imaging, biochemistry and genetics are invited to apply to this opportunity. Graduate students who are already involved in K, U, or H research are no...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 16, 2020 Category: Research Source Type: funding

KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
The purpose of the Kidney, Urology or Hematology (KUH) Predoctoral to Postdoctoral Fellow Transition Awards (F99/K00) is to recruit exceptional graduate students from diverse research fields to pursue postdoctoral training focused on Kidney, Urology or Hematology (K, U, or H) research. Talented graduate students from disciplines including, but not limited to, engineering, statistics, data science, imaging, biochemistry and genetics are invited to apply to this opportunity. Graduate students who are already involved in K, U, or H research are not eligible for the F99/K00 award and are instead encouraged to apply for the Rut...
Source: NIDDK Funding Opportunities - January 16, 2020 Category: Endocrinology Source Type: funding

Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations
Notice NOT-HG-20-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 13, 2020 Category: Research Source Type: funding

Important Reminders for Fellowship and Career Development Applicants
Planning to apply for a fellowship or career development award? If so, don’t forget your ORCID iD. We encourage everybody from graduate students to senior scientists to register for an ORCID account and link it to their eRA Commons personal profile (see this eRA video for a quick step-by-step). But for some grant applicants, it’s an absolute must. ORCID iDs are required for PD/PIs on individual fellowship and career development applications submitted for due dates on or after January 25, 2020. Our eRA systems will check the PD/PI eRA Commons IDs on all submitted fellowship and career developme...
Source: NIH Extramural Nexus - January 6, 2020 Category: Research Authors: NIH Staff Tags: Policy Top Stories career development award eRA Commons fellowship ORCID Source Type: funding

Predicting Translational Progress from Citations of NIH-Supported Fundamental Research
This study suggests that predictions of translational research activity can be made within a relatively short period of time after publication. Such predictions could be considered as part of a holistic approach to decision-making (such as the development of new funding opportunities), alongside expert opinion and other metrics. (Source: NIH Extramural Nexus)
Source: NIH Extramural Nexus - December 17, 2019 Category: Research Authors: Mike Lauer Tags: blog Open Mike citations iCite Open Citation Collection Source Type: funding

Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-076 from the NIH Guide for Grants and Contracts. Reissue of PAR-17-096. The Jointly Sponsored NIH Predoctoral Training Program in the Neurosciences (JSPTPN) is an institutional program that supports broad and fundamental research training in the neurosciences. In addition to a broad education in the neurosciences, a key component will be a curriculum that provides a strong foundation in experimental design, statistical methodology and quantitative reasoning. JSPTPN programs are intended to be 2 years in duration and students may only be appointed to this training grant during the first 2 years o...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 11, 2019 Category: Research Source Type: funding

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-074 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic. Specifically, the focus of this FOA is on the adaption and clinical validation of molecular/cellular/imaging markers (referred to as "markers" r "biomarkers") for cancer detection, diagnosis, prognosis, monitoring, and prediction of response in treatment, as well as markers for cancer control and prevention. Research applications may s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 10, 2019 Category: Research Source Type: funding

Fine-Mapping Genome-Wide Associated Loci to Identify Proximate Causal Mechanisms of Serious Mental Illness (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-21-100 from the NIH Guide for Grants and Contracts. Genome-wide association studies (GWAS) have identified statistical relationships between tens of thousands of common single nucleotide variants and over a thousand traits. Due to the correlated nature of nearby genetic variants, GWAS implicate regions of the genome and do not necessarily pinpoint the causal variant(s), gene(s) or mechanism(s) underlying the trait association. The purpose of this funding opportunity announcement is to support systematic fine-mapping of genome-wide significant risk loci associated with serious mental illnesses th...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 27, 2019 Category: Research Source Type: funding

Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
Funding Opportunity RFA-MH-20-510 from the NIH Guide for Grants and Contracts. NIMH seeks applications for innovative research projects to test strategies to increase the reach, efficiency, effectiveness, and quality of digital mental health interventions. This FOA is intended to support the development of digital health test beds that leverage well-established digital mental health platforms ,to rapidly refine and optimize existing evidence-based digital health interventions and conduct clinical trials testing digital mental health interventions that are statistically powered to provide a definitive answer regarding the ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 25, 2019 Category: Research Source Type: funding

NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP-ENDURE) (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-20-015 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIH Blueprint R25 program is to encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical, behavioral, and clinical research workforce, to pursue further studies or careers in research. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development, Research Expe...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 19, 2019 Category: Research Source Type: funding

NIDCR Research Grants for Analyses of Existing Genomics Data (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-045 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to announce support for meritorious research projects that address research questions relevant to human dental, oral, or craniofacial (DOC) conditions or traits through analyzing existing and publicly available genomics data using statistical and computational approaches. Data analysis of each project can be performed using exiting and/or novel methods to be developed in the same project, including machine learning-based methods (ML). In addition to analysis of existing data, experimental or in silico work should be prop...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 8, 2019 Category: Research Source Type: funding

NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-046 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide support for meritorious research projects that address research questions relevant to human dental, oral, or craniofacial (DOC) conditions or traits through analyzing existing and publicly genomics data using statistical and computational approaches. Data analysis of each project can be performed using exiting and/or novel methods to be developed in the same project, including machine learning-based methods (ML). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 8, 2019 Category: Research Source Type: funding

Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-19-020 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications from integrative teams and individual investigators for large-scale complex multi-disciplinary Functional Genomics Projects (FGPs) to determine the contributions and mechanisms underlying the contribution of associated variants for type 1 diabetes (T1D). Genome-wide association studies (GWAS) and other genomic studies of T1D have found many variants that are statistically associated with disease risk or disease protection, but they have not clearly shown which variants in genom...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2019 Category: Research Source Type: funding

Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) encourages applications from integrative teams and individual investigators for large-scale complex multi-disciplinary Functional Genomics Projects (FGPs) to determine the contributions and mechanisms underlying the contribution of associated variants for type 1 diabetes (T1D). Genome-wide association studies (GWAS) and other genomic studies of T1D have found many variants that are statistically associated with disease risk or disease protection, but they have not clearly shown which variants in genomic elements cause these effects or how they result in differences in function. A...
Source: NIDDK Funding Opportunities - November 6, 2019 Category: Endocrinology Source Type: funding

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network (NCTN)(U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-20-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits renewal applications for Biobanks that will support the following NCI clinical trial programs: The NCI National Clinical Trials Network (NCTN; https://research.usc.edu/nci-national-clinical-trials-network-nctn-program/), and NCI Community Oncology Research Program (NCORP). The NCTN Biospecimen Bank (also referred to as NCTN Biobanks) will be responsible for collecting, processing, storing, and distributing well-annotated human specimens from patients with cancer who are participating in NCI-f...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 24, 2019 Category: Research Source Type: funding

Transdisciplinary Research in Principles of Data Science Phase II (TRIPODS)
Letter of Intent Window: November 20, 2019 Program Guidelines: NSF 19-604Transdisciplinary Research In Principles Of Data Science (TRIPODS) aims to bring together the statistics, mathematics, and theoretical computer science communities to develop the theoretical foundations of data science through integrated research and training activities.  Phase I, described in solicitation NSF 16-615, supported the development of small collaborative Institutes.  Phase II will support a smaller number of larger Institutes, selected from the Phase I ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505663&WT.mc_i...
Source: NSF Upcoming Due Dates - October 21, 2019 Category: Science Source Type: funding

Understanding the Functional Contributions and Mechanisms of Type 2 Diabetes Disease-associated Variants (UM1 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-19-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications from integrative teams and individual investigators for large-scale complex multi-disciplinary Functional Genomics Projects (FGPs) to determine the contributions and mechanisms underlying the contribution of risk-associated variants and their downstream effector transcripts for type 2 diabetes (T2D). The intent is to generate knowledge and tools to enable the identification of putative biomarkers and therapeutic targets by future efforts. Genome-wide association studies (GWAS) ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 27, 2019 Category: Research Source Type: funding

Understanding the Functional Contributions and Mechanisms of Type 2 Diabetes Disease-associated Variants (UM1 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) encourages applications from integrative teams and individual investigators for large-scale complex multi-disciplinary Functional Genomics Projects (FGPs) to determine the contributions and mechanisms underlying the contribution of risk-associated variants and their downstream effector transcripts for type 2 diabetes (T2D). The intent is to generate knowledge and tools to enable the identification of putative biomarkers and therapeutic targets by future efforts. Genome-wide association studies (GWAS) and other genomic studies of T2D and its complications have found many variants ...
Source: NIDDK Funding Opportunities - September 27, 2019 Category: Endocrinology Source Type: funding

Limited Competition: AIDS Malignancy Consortium (AMC) (UM1 Clinical Trials Required)
Funding Opportunity RFA-CA-19-056 from the NIH Guide for Grants and Contracts. The purpose of the proposed Funding Opportunity Announcement (FOA) is to continue support for AIDS Malignancy Consortium (AMC). AMC is a major infrastructure intended to stimulate cooperative research efforts in the following areas: 1) Design, development, and evaluation of clinical interventions for the prevention and treatment of HIV-associated malignancies; Development of more effective therapeutics and management strategies for HIV-associated malignancies; Investigation of the biology of HIV malignancies within the context of clinical trial...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2019 Category: Research Source Type: funding

Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R01 - Clinical Trials Not Allowed)
Funding Opportunity RFA-DA-20-006 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis. It is expected that with the development and application of novel computational, bioinformatics, statistical, and analytical approaches, previously inaccessible insights will reveal new aspects of addiction biology. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2019 Category: Research Source Type: funding

Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21 - Clinical Trials Not Allowed)
Funding Opportunity RFA-DA-20-007 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis. It is expected that with the development and application of novel computational, bioinformatics, statistical, and analytical approaches, previously inaccessible insights will reveal new aspects of addiction biology. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2019 Category: Research Source Type: funding

Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-20-300 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the development or application of advanced computational and statistical tools to integrate brain tissue and single-cell genomic data in order to advance our understanding of the cell type-specific gene regulatory networks and biological pathways involved in the pathogenesis and pathophysiology of mental disorders. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 26, 2019 Category: Research Source Type: funding

Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed)
Funding Opportunity RFA-DA-20-008 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis. It is expected that with the development and application of novel computational, bioinformatics, statistical, and analytical approaches, previously inaccessible insights will reveal new aspects of addiction biology. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2019 Category: Research Source Type: funding

Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 - Clinical Trials Not Allowed)
Funding Opportunity RFA-DA-20-009 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis. It is expected that with the development and application of novel computational, bioinformatics, statistical, and analytical approaches, previously inaccessible insights will reveal new aspects of addiction biology. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2019 Category: Research Source Type: funding

NIH Inclusion Data by Research and Disease Category Now Available
This reporting step continues our move towards enhancing transparency and accountability of the research we support. As part of implementing the 21st Century Cures Act and responding to recommendations from the Government Accountability Office, public reporting by NIH Research, Condition, and Disease Classification (RCDC) category helps ensure that women and minorities are appropriately included in biomedical research across a diverse array of diseases and conditions. At a recent meeting of the NIH Advisory Committee on Research on Women’s Health (go to 02:45), where this announcement was made, we also reported that ...
Source: NIH Extramural Nexus - May 6, 2019 Category: Research Authors: Janine Clayton, Dawn Corbett, Marie Bernard, and Mike Lauer Tags: blog Open Mike Inclusion RCDC Source Type: funding

Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)
The objectives of the meeting(s) supported by this FOA are to provide these early stage HIV/AIDS researchers with guidance on conducting preclinical research to inform clinical trials on reducing the incidence of HIV/AIDS infection, including vaccine development and testing; developing next-generation HIV therapies, including potential cure therapies; treatment of HIV-associated coinfections, comorbidities and complications; and infection prevention strategies. In addition to guidance on translating results to clinical trials, the conference should target developing skills related to networking, grantsmanship, and goal/mil...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 3, 2019 Category: Research Source Type: funding

NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-260 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity announcement (FOA) is to fund meritorious vision-related research projects that involve secondary data analyses using existing database resources. The development of statistical methodology necessary for improving methods to analyze vision health data using existing vision data may also be proposed. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 24, 2019 Category: Research Source Type: funding

How Many Researchers? …Revisited…the FY 2018 NIH’s Cumulative Investigator Rate
In March 2018, we showed data suggesting that, despite still being in a state of hyper-competition (as described in this post), the severity may be lessening. The number of unique applicants for NIH research project grants (RPGs) appeared to stabilize after many years of uninterrupted growth. Furthermore, a person-based metric, called the cumulative investigator rate, started to rise in fiscal year (FY) 2015 for RPGs after declines in previous years. With FY 2018 grants information now available in the NIH Data Book, we wanted to see if this positive trend continued. As in my March 2018 blog, the FY 2018 cumulative...
Source: NIH Extramural Nexus - April 22, 2019 Category: Research Authors: Mike Lauer Tags: blog Open Mike cumulative funding rate Funding data Source Type: funding

Methodology, Measurement, and Statistics (MMS)
Available Formats: HTML: https://www.nsf.gov/pubs/2019/nsf19575/nsf19575.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2019/nsf19575/nsf19575.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf19575This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - April 9, 2019 Category: Science Source Type: funding

Get the Latest on an NIH Institute or Center ’s Funding Strategies
Interested in the latest funding policies from your favorite NIH Institute or Center (IC)? Find funding strategies for each NIH IC, in addition to NIH fiscal policies and budget overview, on our NIH Funding Strategies page. Use this information as you prepare your application to better understand NIH’s approach to grant funding and stay updated on key budget policies. For quick summary statistics on NIH-funded research by IC (and much more), explore the newly-redesigned NIH Data Book. (Source: NIH Extramural Nexus)
Source: NIH Extramural Nexus - April 1, 2019 Category: Research Authors: NIH Staff Tags: New Resources funding strategies Source Type: funding

ITCR: innovative algorithms (R21 Clinical Trial Optional)
Funding Opportunity RFA-CA-19-038 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 27, 2019 Category: Research Source Type: funding

Institutional Translational Research Training Program (T32)
Funding Opportunity PAR-19-228 from the NIH Guide for Grants and Contracts. The purpose of the NINDS Institutional Translational Research Training Program is to equip trainees with the knowledge and skills needed to advance basic research toward clinical application. These programs will support, students and/or postdocs conducting basic, disease-relevant research in an environment that includes 1) basic neuroscientists and clinicians who are actively engaged in collaborative research projects, 2) neuroscience researchers with expertise in translational processes who are conducting research designed to move basic discoveri...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 22, 2019 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Computational and Statistical Methods to Enhance Discovery from Health Data
Notice NOT-LM-19-003 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 19, 2019 Category: Research Source Type: funding

Notice of Changes to RFA-AI-19-002 "HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (UM1 Clinical Trial Required)"
Notice NOT-AI-19-051 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2019 Category: Research Source Type: funding

Limited Competition for the Continuation of the Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) Data Coordinating Center (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-19-501 from the NIH Guide for Grants and Contracts. The Chronic Kidney Disease Biomarkers Consortium [CKD BioCon] was established in September 2009 as a result of RFA-DK-08-015 [Chronic Kidney Disease Biomarker Discovery and Validation Consortium (U01)] to develop, validate and qualify biomarkers based on existing biosamples from well-characterized CKD patients with longitudinal follow-up. The second phase of the CKD BioCon was funded in September 2014, pursuant to RFA DK-14-011. Two additional Centers were brought into the Consortium in 2015. The CKD BioCon currently consists of eight Participa...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 8, 2019 Category: Research Source Type: funding

Limited Competition for the Continuation of the Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) Data Coordinating Center (U01 Clinical Trial Not Allowed)
The Chronic Kidney Disease Biomarkers Consortium [CKD BioCon] was established in September 2009 as a result of RFA-DK-08-015 [Chronic Kidney Disease Biomarker Discovery and Validation Consortium (U01)] to develop, validate and qualify biomarkers based on existing biosamples from well-characterized CKD patients with longitudinal follow-up. The second phase of the CKD BioCon was funded in September 2014, pursuant to RFA DK-14-011. Two additional Centers were brought into the Consortium in 2015. The CKD BioCon currently consists of eight Participating Clinical Centers (PCCs) and is actively engaged in multiple research protoc...
Source: NIDDK Funding Opportunities - March 8, 2019 Category: Endocrinology Source Type: funding

NINDS Institutional Research Training Program (T32)
Funding Opportunity PAR-19-211 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide support for institutional research training programs in areas relevant to the NINDS mission. These institutional research training programs should produce well-trained neuroscientists who leave the program with the research skills and scientific knowledge to make a significant contribution to neuroscience research. Programs should be designed to enhance the breadth and depth of training in NINDS mission areas by incorporating didactic, research and career development components in the context of a defined scie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 6, 2019 Category: Research Source Type: funding

Seeking Input on the Need to Enhance Access to NIH Grants Data
NIH has long been committed to transparency into who and what we fund. We have previously discussed the value of freely-available web tools that allow you to gain insight into NIH funding decisions. Award data available via RePORT and RePORTER, for instance, include non-sensitive information such as awardee institution, principal investigator, funding levels, research abstracts, as well as associated publications, patents, and other project outcomes. Better yet, if you want to see all of these data all at once, then ExPORTER allows you to download over 25 years’ worth of such non-sensitive NIH grant award data. R...
Source: NIH Extramural Nexus - March 4, 2019 Category: Research Authors: Mike Lauer Tags: blog Open Mike Administrative Data Data enclave RFI Source Type: funding